Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Regulatory Considerations for the Development of Autologous Induced Pluripotent Stem Cell Therapies

1 Jul 2010

Abstract excerpt

Induced pluripotent stem (iPS) cells offer tremendous opportunity for the creation of autologous cellular therapies, in which gene correction or the avoidance of immune response issues are desirable. In addition, iPS cells avoid the ethical concerns raised by the sourcing of human embryonic stem cells (hESCs) from embryos. iPS cells share many characteristics with hESCs and it is anticipated that existing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to CRISPR and Genetic Engineering
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20632860
DOI: 10.2217/rme.10.55

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Regulatory Considerations for the Development of Autologous Induced Pluripotent Stem Cell TherapiesPMID 20632860Read ↗

Translational Prospects for Human Induced Pluripotent Stem CellsSemantic proximity Read ↗

Key Anticipated Regulatory Issues for Clinical Use of Human Induced Pluripotent Stem CellsSemantic proximity Read ↗

Do Human Leukocyte Antigen-Typed Cellular Therapeutics Based on Induced Pluripotent Stem Cells Make Commercial Sense?Semantic proximity Read ↗

Inducible pluripotent stem cells: not quite ready for prime time?Semantic proximity Read ↗

Methods of induced pluripotent stem cells for clinical applicationSemantic proximity Read ↗

Roadblocks in the Path of iPSC to the ClinicSemantic proximity Read ↗

The Potential for Immunogenicity of Autologous Induced Pluripotent Stem Cell-derived TherapiesSemantic proximity Read ↗

Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stabilitySemantic proximity Read ↗

Roadblocks en route to the clinical application of induced pluripotent stem cellsSemantic proximity Read ↗

The safety of human pluripotent stem cells in clinical treatmentSemantic proximity Read ↗

An introduction to induced pluripotent stem cellsSemantic proximity Read ↗

Research and therapy with induced pluripotent stem cells (iPSCs): social, legal, and ethical considerationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.